scispace - formally typeset
C

Christopher A. Haiman

Researcher at University of Southern California

Publications -  783
Citations -  65352

Christopher A. Haiman is an academic researcher from University of Southern California. The author has contributed to research in topics: Breast cancer & Genome-wide association study. The author has an hindex of 106, co-authored 687 publications receiving 54813 citations. Previous affiliations of Christopher A. Haiman include University of California, San Francisco & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population.

Karol Estrada, +55 more
- 11 Jun 2014 - 
TL;DR: A single low-frequency variant in the MODY3-causing gene HNF1A that is associated with type 2 diabetes in Latino populations and may affect protein function is identified and may have implications for screening and therapeutic modification in this population.
Journal ArticleDOI

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21

Christopher A. Haiman, +62 more
- 01 Jun 2011 - 
TL;DR: A new risk variant on chromosome 17q21 is identified, ∼5% in men of African descent, whereas it is rare in other populations (<1%).
Journal ArticleDOI

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers

Juliet D. French, +214 more
TL;DR: Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified three independent association signals for estrogen-receptor-positive tumors at 11q13, and Chromatin conformation studies demonstrate that these enhancer and silencer elements interact with each other and with their likely target gene, CCND1.
Journal ArticleDOI

Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction

David V. Conti, +254 more
- 04 Jan 2021 - 
TL;DR: This paper conducted a meta-analysis of prostate cancer genome-wide association studies (107,247 cases and 127,006 controls) and identified 86 new genetic risk variants independently associated with prostate cancer risk, bringing the total to 269 known risk variants.